Latest News and Press Releases

WINNIPEG, MANITOBA--(Marketwired - June 21, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...

WINNIPEG, MANITOBA--(Marketwired - June 5, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...

WINNIPEG, MANITOBA--(Marketwired - June 2, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Company" or "Kane Biotech") today announced the intention of the Company to undertake a...

LONDON, UNITED KINGDOM--(Marketwired - May 5, 2016) - Philip Renaud (11 The Little Boltons, London, England, SW10 9LT), the Chairman and a director of Kane Biotech Inc. (the...

WINNIPEG, MANITOBA--(Marketwired - May 4, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Company" or "Kane Biotech") is pleased to announce additional information regarding the...

WINNIPEG, MANITOBA--(Marketwired - May 4, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Company" or "Kane Biotech") is pleased to announce the closing of its rights offering (the...

WINNIPEG, MANITOBA--(Marketwired - April 26, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Company" or "Kane Biotech" or "Kane") is pleased to announce that it has received a...

WINNIPEG, MANITOBA--(Marketwired - April 7, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") announced that on April 7, 2016, it issued 254,369 common shares of the...

WINNIPEG, MANITOBA--(Marketwired - March 29, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Company" or "Kane Biotech") today announced that it will be offering rights ("Rights") to...

WINNIPEG, MANITOBA--(Marketwired - March 1, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Company" or "Kane Biotech") is pleased to announce it will be launching its bluestem™...